{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/OCUL/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-17T01:27:40.007Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9586,"canonical_name":"OCULAR THERAPEUTIX, INC","cik":"0001393434","uei":null,"lei":null,"duns":null,"ticker":"OCUL"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":39},"count":39,"timeline":[{"ts":"2026-10-13","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-10-13","url_slug":"/sec/cik-0001393434/4/0001104659-26-115551","accession_number":"0001104659-26-115551","importance":30},{"ts":"2026-10-08","kind":"sec.filing","form_type":"144","title":"144 — OCULAR THERAPEUTIX, INC — 2026-10-08","url_slug":"/sec/cik-0001393434/144/0001950047-26-010123","accession_number":"0001950047-26-010123","importance":30},{"ts":"2026-10-06","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-10-06","url_slug":"/sec/cik-0001393434/4/0001104659-26-114080","accession_number":"0001104659-26-114080","importance":30},{"ts":"2026-10-06","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-10-06","url_slug":"/sec/cik-0001393434/4/0001104659-26-114081","accession_number":"0001104659-26-114081","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"144","title":"144 — OCULAR THERAPEUTIX, INC — 2026-10-02","url_slug":"/sec/cik-0001393434/144/0001950047-26-009997","accession_number":"0001950047-26-009997","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"144","title":"144 — OCULAR THERAPEUTIX, INC — 2026-10-02","url_slug":"/sec/cik-0001393434/144/0001950047-26-009999","accession_number":"0001950047-26-009999","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-09-02","url_slug":"/sec/cik-0001393434/4/0001104659-26-104727","accession_number":"0001104659-26-104727","importance":30},{"ts":"2026-08-31","kind":"sec.filing","form_type":"144","title":"144 — OCULAR THERAPEUTIX, INC — 2026-08-31","url_slug":"/sec/cik-0001393434/144/0001950047-26-008839","accession_number":"0001950047-26-008839","importance":30},{"ts":"2026-08-26","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-08-26","url_slug":"/sec/cik-0001393434/4/0001104659-26-101667","accession_number":"0001104659-26-101667","importance":30},{"ts":"2026-08-26","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-08-26","url_slug":"/sec/cik-0001393434/4/0001104659-26-101670","accession_number":"0001104659-26-101670","importance":30},{"ts":"2026-08-26","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-08-26","url_slug":"/sec/cik-0001393434/4/0001104659-26-101671","accession_number":"0001104659-26-101671","importance":30},{"ts":"2026-08-26","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-08-26","url_slug":"/sec/cik-0001393434/4/0001104659-26-101674","accession_number":"0001104659-26-101674","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"144","title":"144 — OCULAR THERAPEUTIX, INC — 2026-08-24","url_slug":"/sec/cik-0001393434/144/0001950047-26-008627","accession_number":"0001950047-26-008627","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"144","title":"144 — OCULAR THERAPEUTIX, INC — 2026-08-24","url_slug":"/sec/cik-0001393434/144/0001950047-26-008628","accession_number":"0001950047-26-008628","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"144","title":"144 — OCULAR THERAPEUTIX, INC — 2026-08-24","url_slug":"/sec/cik-0001393434/144/0001950047-26-008629","accession_number":"0001950047-26-008629","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"144","title":"144 — OCULAR THERAPEUTIX, INC — 2026-08-24","url_slug":"/sec/cik-0001393434/144/0001950047-26-008630","accession_number":"0001950047-26-008630","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"10-Q","title":"10-Q — OCULAR THERAPEUTIX, INC — 2026-08-03","url_slug":"/sec/cik-0001393434/10-q/0001104659-26-089450","accession_number":"0001104659-26-089450","importance":45},{"ts":"2026-08-03","kind":"sec.filing","form_type":"8-K","title":"8-K — OCULAR THERAPEUTIX, INC — 2026-08-03","url_slug":"/sec/cik-0001393434/8-k/0001104659-26-089443","accession_number":"0001104659-26-089443","importance":35},{"ts":"2026-08-03","kind":"sec.filing","form_type":"S-8","title":"S-8 — OCULAR THERAPEUTIX, INC — 2026-08-03","url_slug":"/sec/cik-0001393434/s-8/0001104659-26-089474","accession_number":"0001104659-26-089474","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — OCULAR THERAPEUTIX, INC — 2026-07-29","url_slug":"/sec/cik-0001393434/schedule-13g-a/0002012383-26-002837","accession_number":"0002012383-26-002837","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-06-18","url_slug":"/sec/cik-0001393434/4/0001104659-26-075709","accession_number":"0001104659-26-075709","importance":30},{"ts":"2026-06-16","kind":"sec.insider.g","reporter":"Dugel Pravin","title":"See Remarks","shares":50092,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-16","kind":"sec.insider.g","reporter":"Dugel Pravin","title":"See Remarks","shares":50092,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-12","kind":"sec.filing","form_type":"8-K","title":"8-K — OCULAR THERAPEUTIX, INC — 2026-06-12","url_slug":"/sec/cik-0001393434/8-k/0001104659-26-073496","accession_number":"0001104659-26-073496","importance":35},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-06-12","url_slug":"/sec/cik-0001393434/4/0001104659-26-073580","accession_number":"0001104659-26-073580","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-06-12","url_slug":"/sec/cik-0001393434/4/0001104659-26-073585","accession_number":"0001104659-26-073585","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-06-12","url_slug":"/sec/cik-0001393434/4/0001104659-26-073586","accession_number":"0001104659-26-073586","importance":30},{"ts":"2026-06-10","kind":"sec.insider.a","reporter":"RAINES MERILEE","title":"","shares":14000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-10","kind":"sec.insider.a","reporter":"LINDSTROM RICHARD L MD","title":"","shares":14000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-10","kind":"sec.insider.a","reporter":"Graves Adrienne L","title":"","shares":14000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-10","kind":"sec.insider.a","reporter":"Warden Charles M","title":"","shares":14000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-10","kind":"sec.insider.a","reporter":"Williams Leslie J.","title":"","shares":14000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-10","kind":"sec.insider.a","reporter":"Hong Seung Suh","title":"","shares":14000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-10","kind":"sec.insider.a","reporter":"Robins Jason Shand","title":"Chief Financial Officer","shares":15441,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — OCULAR THERAPEUTIX, INC — 2026-06-05","url_slug":"/sec/cik-0001393434/4/0001104659-26-070956","accession_number":"0001104659-26-070956","importance":30},{"ts":"2026-06-03","kind":"sec.form144","reporter":"NADIA K. WAHEED","title":"Officer","shares":14828,"usd_value":122648,"security_title":"Common","approx_sale_date":"2026-06-03","accession_number":"0001950047-26-005548","importance":40.024529664},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"Waheed Nadia","title":"Chief Medical Officer","shares":14828,"price_per_share":8.27,"usd_value":122628,"security_title":"Common Stock","importance":35.12262756},{"ts":"2026-06-03","kind":"sec.filing","form_type":"144","title":"144 — OCULAR THERAPEUTIX, INC — 2026-06-03","url_slug":"/sec/cik-0001393434/144/0001950047-26-005548","accession_number":"0001950047-26-005548","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — OCULAR THERAPEUTIX, INC — 2026-05-15","url_slug":"/sec/cik-0001393434/schedule-13g-a/0001172661-26-002031","accession_number":"0001172661-26-002031","importance":30}]}